Hostname: page-component-848d4c4894-m9kch Total loading time: 0 Render date: 2024-05-26T12:20:17.507Z Has data issue: false hasContentIssue false

Multiple measures, methods, and moments: a factor-analytic investigation of change in depressive symptoms during acute-phase cognitive therapy for depression

Published online by Cambridge University Press:  17 January 2005

JEFFREY R. VITTENGL
Affiliation:
Division of Social Science, Truman State University, Kirksville, MO, USA
LEE ANNA CLARK
Affiliation:
Department of Psychology, University of Iowa, Iowa City, IA, USA
DOLORES KRAFT
Affiliation:
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA
ROBIN B. JARRETT
Affiliation:
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA

Abstract

Background. Researchers and clinicians use a variety of measures to assess depressive symptoms, including clinician reports [for example the 17-item Hamilton Rating Scale for Depression (HRSD-17) and the 30-item Inventory for Depressive Symptomatology – Clinician Report (IDS-C-30)]; and patient reports [for example, the Beck Depression Inventory (BDI) and the 30-item Inventory for Depressive Symptomatology – Self-Report (IDS-SR-30)]. Although their concurrent convergent validity is well established, the degree to which these measures reflect the same pattern and level of change during treatment is unclear.

Method. We assessed depressive symptoms with two clinician (HRSD-17, IDS-C-30) and two patient (BDI, IDS-SR-30) reports on 14–15 occasions in 127 out-patients with recurrent major depressive disorder treated with 20 sessions of acute-phase cognitive therapy.

Results. Factor analyses revealed that time was the major source of variation in depressive symptom severity and change, with distinct ‘early’ and ‘late’ assessment factors, regardless of measure or rater (patient v. clinician). Average symptom severity decreased rapidly on all measures until mid-treatment, after which gradual decreases continued through the end of treatment. Effect sizes for pre- to post-treatment change were large for all measures (d=1·9–2·2), although there were significant differences among measures at some time-points.

Conclusions. The HRSD-17, BDI, IDS-C-30 and IDS-SR-30 reflect essentially the same symptom severity and change constructs during acute-phase cognitive therapy. Clinicians and researchers using one of these measures may estimate scores on the others with the provided common-factor conversions.

Type
Research Article
Copyright
© 2005 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)